An overview of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort (GBCS-CVD): A platform for multidisciplinary collaboration

Journal of Human Hypertension

Volumn 24, Issue 2, 2010, Pages 139-150

  Jiang, C Q ^a   Lam, T H ^b   Lin, J M ^a   Liu, B ^a   Yue, X J ^a   Cheng, K K ^c   Tomlinson, B ^d   Wong, K S ^d   Cheung, B M Y ^c   Thomas, G N ^c  

^a Guangzhou No 12 Hospital   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Arterial stiffness; Biobank; Carotid artery intima media thickness; Cerebral artery stenoses; China; Cohort

Indexed keywords

ADIPOCYTOKINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY FAT; CARDIOVASCULAR DISEASE; CHINA; COHORT ANALYSIS; COOPERATION; DRINKING BEHAVIOR; ENERGY EXPENDITURE; FEMALE; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; RACE DIFFERENCE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL SPECIMEN BANKS; CARDIOVASCULAR DISEASES; CHINA; COHORT STUDIES; COOPERATIVE BEHAVIOR; DISEASE PROGRESSION; ENGLAND; ENVIRONMENT; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; RISK ASSESSMENT; RISK FACTORS;

EID: 75149121880     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.52     Document Type: Article

References (32)

1. Jiang C, Thomas GN, Lam TH, Schooling CM, ZhangW, Lao X et al. Cohort profile: the Guangzhou Biobank Cohort Study, a Guangzhou-Hong Kong-Birmingham collaboration. Int J Epidemiol 2006; 35: 844-852. (Pubitemid 44540731)
2. National Bureau of Statistics of P.R. China. China Statistical Yearbook 2007. China Statistics Press: Beijing, 2007.
3. OECD. Understanding Economic Growth. Palgrave Macmillan: Basingstoke, UK, 2004.
4. MacFarquhar R, Schoenhals M. Mao's Last Revolution. Harvard University Press: Boston, 2006.
5. Peng X. Demographic consequences of the Great Leap Forward in China's provinces. Popul Dev Rev 1987; 13: 639-670.
6. Yin P, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet 2007; 370: 751-757.
7. Thom TJ, Epstein FH. Heart disease, cancer and stroke mortality trends and their interrelations. An international perspective. Circulation 1994; 90: 574-582.
8. World Health Organization. World Health Statistics Annual 1996. WHO: Geneva, 1998.
9. Young RP, Thomas GN, Critchley JAJH, Tomlinson B, Woo KS, Sanderson JE. Interethnic differences in coronary heart disease mortality in 25 populations: association with the angiotensin-converting enzyme DD genotype frequency. J Cardiovasc Risk 1998; 5: 303-307.
10. Woo KS, Chook P, Young RP, Sanderson JE. New risk factors for coronary heart disease in Asia. Int J Cardiol 1997; 62(Suppl 1): S39-S42.
11. Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organization Multinational Study of Vascular Disease in Diabetics. Diabetologia 1985; 28: 615-640.
12. The Global Lower Extremity Amputation Study Group. Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia. The global lower extremity amputation study group. Br J Surg 2000; 87: 328-337.
13. Thomas GN, Critchley JAJH, Tomlinson B, Cockram CS, Chan JCN. Peripheral vascular disease in Type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 2003; 20: 988-995.
14. Wong KS, Huang YN, Gao S, Lam WW, Chan YL, Kay R. Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998; 50: 812-813.
15. Kay R, Woo J, Kreel L, Wong HY, Teoh T, Nicholls MG. Stroke subtypes among Chinese living in Hong Kong. The Shatin Stroke Registry. Neurology 1992; 42: 985-987.
16. Feldmann E, Daneault N, Kwan E, Ho KJ, Pessin MS, Lagenberg P et al. Chinese-White differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40: 1541-1545.
17. Wong KS, Huang YN, Gao S, Lam WWM, Chan YL. Cerebrovascular disease among Chinese populations- recent epidemiological and neuroimaging studies. Hong Kong Med J 2001; 7: 50-57.
18. Wong KS, Li H, Chan YL, Ahuja A, Lam WWM, Wong A et al. Use of transcranial doppler ultrasound to predict outcome in patients with intracranial largeartery occlusive disease. Stroke 2000; 31: 2641-2647.
19. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996; 27: 1974-1980.
20. Worth RM, Kato H, Rhoads GG, Syme SL. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. Am J Epidemiol 1975; 102: 481-490.
21. International Physical Activity Questionnaire. http:// www.ipaqkise/, accessed 15 December 2005.
22. Livak KJ. Allelic discrimination using fluorogenic probes and the 5 nuclease assay. Genet Anal 1999; 14: 143-149.
23. Thomas GN, Lin JW, Lam WWM, Tomlinson B, Yeung VTF, Chan JCN et al. Middle cerebral artery stenosis in Type 2 diabetic Chinese patients is associated with conventional risk factors but not with polymorphisms of the renin-angiotensin system genes. Cerebrovasc Dis 2003; 16: 217-223.
24. Thomas GN, Lin JW, Lam WW, Tomlinson B, Yeung V, Chan JC et al. Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in Type 2 diabetic Chinese patients. Diabetologia 2004; 47: 1528-1534.
25. Thomas GN, Lin JW, Lam WW, Tomlinson B, Yeung V, Chan JC et al. Increasing severity of cardiovascular risk factors with increasing middle cerebral artery stenotic involvement in Type 2 diabetic Chinese patients with asymptomatic cerebrovascular disease. Diabetes Care 2004; 27: 1121-1126.
26. Thomas GN, Chook P, Qiao M, Huang XS, Leong HC, Celermajer DS et al. Deleterious impact of 'high normal' glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol 2004; 24: 739-743.
27. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
28. Thomas GN, Ho S-Y, Lam KSL, Janus ED, Hedley AJ, Lam TH et al. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. Obes Res 2004; 12: 1805-1813.
29. Chu JY, Huang W, Kuang SQ, Wang JM, Xu JJ, Chu ZT et al. Genetic relationship of populations in China. Proc Natl Acad Sci USA 1998; 95: 11763-11768.
30. Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (Inter- ASIA). Diabetologia 2003; 46: 1190-1198.
31. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002; 40: 920-927.
32. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.